Introduction
============

Alzheimer's disease (AD), the most common cause of dementia worldwide, is becoming more prevalent due to the aging population, and represents one of the grand challenges to health care systems \[[@r1]\]. Although substantial progress has been made in the identification of disease-related molecular and cellular processes over the last decade, the molecular mechanisms that underlie the pathogenesis of AD remain largely unknown \[[@r2]\], and none of the pharmacological treatments presently available for AD are able to stop or slow down the progression of this disease \[[@r3]\].Therefore, further investigation of the underlying disease mechanisms are urgently required in order to better understand AD and to facilitate the development of effective therapeutic strategies.

Currently, accumulating evidence indicates that noncoding RNAs (ncRNAs), especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are strongly implicated in AD-associated pathophysiology, including amyloid-β plaques and neurofibrillary tangles, synaptic loss and neuronal death \[[@r4],[@r5]\]. In a previous study, we investigated the hippocampal expression patterns of dysregulated lncRNAs in a rat model of AD using microarray analysis and demonstrated that lncRNAs contributed to the pathogenesis of AD \[[@r6]\]. To further investigate the regulatory role of ncRNAs in AD, we focused upon circRNAs, a class of ncRNAs that are highly expressed in the mammalian brain \[[@r7],[@r8]\], and can regulate transcriptional and post-transcriptional gene expression \[[@r9]\]. Unlike linear RNA, circRNA is formed with covalently closed continuous loops without 5'-3' polarity and a poly(A) tail, and might function as microRNA sponges to modulate the expression of parental genes through the competing endogenous RNA (ceRNA) network \[[@r10]\]. Recent studies have provided evidence that the circRNA-associated ceRNA network may play a crucial role in many disease processes, including AD \[[@r11]\]. For example, Lukiw et al. \[[@r12],[@r13]\] demonstrated that circRNA-7(ciRS-7) acted as a natural miRNA sponge for miRNA-7 and regulated the expression of ubiquitin-conjugating enzyme E2A (UBE2A) and the epidermal growth factor receptor (EGFR) in sporadic AD hippocampal brain. Zhang et al. \[[@r14]\] characterized circRNA-associated-ceRNA networks in the cerebral cortex of senescence-accelerated mouse prone 8(SAMP8). Additionally, Zhong et al. \[[@r15]\] described the expression of circRNAs in different ages of SAMP8 mice. However, the potential role of circRNAs in the pathogenesis of AD is still in its infancy and has yet to be characterized, particularly the role of circRNA-associated-ceRNA networks in the hippocampus of AD.

In the present study, we used a microarray analysis approach to identify differentially-expressed profiles of circRNAs, miRNAs and mRNAs in the hippocampus of Aβ~1-42~-induced AD model rats, which is a useful experimental animal model of AD which emphasizes the inflammatory component of the disease pathology, and strongly complements the use of transgenic animal models in advancing our understanding of AD \[[@r16]\]. Next we performed Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. We also constructed a circRNA-associated-ceRNA network. Findings arising from this study will expand our understanding of the potential role of the circRNA-associated-ceRNA network involved in AD pathogenesis and therapeutic strategy.

RESULTS
=======

Altered circRNA, miRNA and mRNA profiles in the AD rat hippocampus
------------------------------------------------------------------

The expression of circRNAs, miRNAs, and mRNAs in the hippocampus of AD rats were profiled using microarrays. Using a threshold of fold change (FC) ≥ 2.0 and a *p*-value \< 0.05, 555 circRNAs, 183 miRNAs, and 319 mRNAs were significantly altered in the AD rat hippocampus compared to sham controls. The results showed that 444 circRNAs, 93 miRNAs, and 173 mRNAs were up-regulated, while 111 circRNAs, 90 miRNAs, and 146 mRNAs were down-regulated. The most up-regulated were circRNA_008964, miR-133a-5p, and BGLAP with FCs of 16.97, 355.67, and 22.96, respectively, whereas circRNA_017759, miR-551b-3p, and IL-1RN were the most down-regulated, with corresponding FCs of 6.32, 257.63 and 14.21. The top 20 up-regulated and 20 down-regulated circRNAs, miRNAs, and mRNAs in the AD group are listed in [Tables 1-3](#t1){ref-type="table"}[](#t2){ref-type="table"}[](#t3){ref-type="table"}. Hierarchical clustering and volcano plot visualization ([Fig. 1 and 2](#f1){ref-type="fig"}[](#f2){ref-type="fig"}) suggested that the expression level of circRNAs, miRNAs and mRNAs were distinguishable and variable.

###### Top 40 differently expressed circRNAs in microarray analysis.

  -------------------- ---------- ---------- ------------- ------------ ------- -------- ------------------- -------------
  circRNA              p-value    FDR        Fold change   Regulation   chrom   strand   circRNA_type        Gene symbol
  rno_circRNA_008964   0.000606   0.094365   16.9714       up           chr2    \+       exonic              Ppp3ca
  mmu_circRNA_32007    0.002111   0.108069   16.57521      up           chr18   \-       sense overlapping   RGD1308601
  rno_circRNA_004560   0.018609   0.182842   10.47134      up           chr14   \-       exonic              RGD1305110
  rno_circRNA_017295   0.037675   0.225271   10.14399      up           chr9    \-       exonic              Clk1
  rno_circRNA_016355   0.029281   0.207134   10.00513      up           chr8    \-       sense overlapping   Birc2
  rno_circRNA_001285   0.01166    0.16506    9.170892      up           chr1    \+       exonic              Pdcd11
  rno_circRNA_011119   0.043819   0.236427   8.989032      up           chr3    \-       exonic              Ext2
  mmu_circRNA_33592    0.023237   0.196417   8.459         up           chr3    \-       exonic              Acvr1
  rno_circRNA_003724   0.044537   0.237503   7.782604      up           chr12   \-       exonic              RGD1309762
  rno_circRNA_010684   0.016463   0.17835    7.75411       up           chr3    \-       exonic              Golga1
  rno_circRNA_011054   0.034331   0.216266   7.619158      up           chr3    \+       intergenic          
  rno_circRNA_007599   0.023829   0.197354   7.284635      up           chr18   \+       sense overlapping   Zfp516
  rno_circRNA_007108   0.028113   0.205101   7.274158      up           chr18   \+       exonic              Wdr33
  mmu_circRNA_24828    0.019181   0.184686   7.260869      up           chr6    \+       sense overlapping   Tssc1
  rno_circRNA_005547   0.015465   0.175514   7.112599      up           chr15   \+       exonic              Mipep
  rno_circRNA_000967   0.014718   0.173347   7.044118      up           chr1    \+       exonic              Cpsf7
  rno_circRNA_015073   0.017918   0.182842   7.039097      up           chr7    \-       exonic              Polr3b
  rno_circRNA_003463   0.013453   0.170196   6.770216      up           chr12   \+       exonic              Slc46a3
  rno_circRNA_002071   0.008468   0.149026   6.626886      up           chr10   \+       exonic              Tekt5
  hsa_circRNA_102043   0.00576    0.138131   6.473515      up           chr10   \+       exonic              Acaca
  rno_circRNA_017759   0.002899   0.111828   6.320172      down         chrX    \+       intergenic          
  mmu_circRNA_36814    0.01092    0.161814   3.519062      down         chr5    \+       exonic              Rad23b
  rno_circRNA_007879   0.017054   0.179628   3.370089      down         chr19   \-       exonic              Nr3c2
  rno_circRNA_001235   0.042661   0.234935   3.322749      down         chr1    \-       exonic              Got1
  rno_circRNA_005560   0.00972    0.154309   2.990798      down         chr15   \+       exonic              Dpysl2
  rno_circRNA_013940   0.00004    0.066585   2.94782       down         chr6    \+       exonic              Ptprn2
  rno_circRNA_013941   0.000249   0.077601   2.893453      down         chr6    \+       exonic              Ptprn2
  rno_circRNA_008623   0.042057   0.233777   2.8228        down         chr2    \+       sense overlapping   Ash1l
  rno_circRNA_013981   0.029554   0.207381   2.812952      down         chr6    \-       exonic              Nrxn1
  rno_circRNA_013026   0.044491   0.23747    2.785261      down         chr5    \+       exonic              Rere
  rno_circRNA_013942   0.000182   0.077601   2.733282      down         chr6    \+       exonic              Ptprn2
  rno_circRNA_013025   0.041907   0.233777   2.704128      down         chr5    \+       sense overlapping   Rere
  mmu_circRNA_31794    0.001829   0.105466   2.669903      down         chr18   \+       exonic              Camk2a
  rno_circRNA_015612   0.029545   0.207381   2.653884      down         chr7    \-       exonic              Trps1
  mmu_circRNA_36813    0.026985   0.203613   2.590337      down         chr5    \+       exonic              Rad23b
  rno_circRNA_013022   0.041158   0.23268    2.585987      down         chr5    \+       exonic              Rere
  rno_circRNA_013943   0.008876   0.15       2.525526      down         chr6    \+       exonic              Ptprn2
  rno_circRNA_011180   0.003519   0.119602   2.509546      down         chr4    \-       exonic              Magi2
  rno_circRNA_011731   0.012178   0.167316   2.50498       down         chr4    \-       exonic              Grin2b
  rno_circRNA_014166   0.017049   0.179628   2.501832      down         chr6    \+       exonic              Dtnb
  -------------------- ---------- ---------- ------------- ------------ ------- -------- ------------------- -------------

###### Top 40 differently expressed miRNAs in microarray analysis.

  ------------------ ---------- ---------- ---------- ------------ ---------- ---------- ---------- ---------- ---------- ----------
  Name               FC         P-value    FDR        Regulation   Sham -1    Sham -2    Sham-3     AD-1       AD-2       AD-3
  rno-miR-133a-5p    355.6778   1.49E-06   0.000597   up           0.030016   0.024263   0.025      9.676819   9.532174   8.988871
  rno-miR-133a-3p    180.9255   0.000918   0.023498   up           0.139021   0.29636    0.278125   52.46193   40.3513    36.27822
  rno-miR-1b         121.9097   0.017959   0.081167   up           0.35545    0.110919   0.207813   37.47377   30.81565   13.89984
  rno-miR-133b-3p    112.2112   0.000352   0.016336   up           0.255924   0.589255   0.5125     59.63959   45.44174   47.2655
  rno-miR-152-5p     77.69073   0.031524   0.108617   up           0.006319   0.010399   0.025      1.654822   1.069565   0.516693
  rno-miR-378a-5p    57.07956   0.00038    0.01635    up           0.053712   0.084922   0.040625   2.900169   3.384348   3.947536
  rno-miR-208b-3p    50.91059   0.017594   0.080291   up           0.020537   0.025997   0.014063   1.159052   1.396522   0.529412
  rno-miR-144-3p     45.24951   5.72E-08   6.88E-05   up           0.104265   0.220104   0.2125     8.164129   8.168696   7.960254
  rno-miR-486        37.36758   0.000367   0.016336   up           0.1406     0.216638   0.253125   7.678511   8.709565   6.419714
  rno-miR-499-5p     33.39683   0.003852   0.038921   up           0.349131   0.221837   0.19375    9.771574   9.996522   5.771065
  rno-miR-10b-5p     33.32301   0.000977   0.023498   up           0.031596   0.025997   0.035938   1.219966   1.074783   0.82194
  rno-miR-155-5p     33.28875   2.36E-07   0.000189   up           0.017378   0.015598   0.010938   0.49577    0.474783   0.491256
  rno-miR-3561-3p    30.31098   0.009789   0.060993   up           0.022117   0.008666   0.014063   0.566836   0.526957   0.265501
  rno-miR-3573-5p    27.40815   0.003971   0.039624   up           0.020537   0.003466   0.010938   0.358714   0.217391   0.381558
  rno-miR-378a-3p    23.9381    0.011289   0.064185   up           0.93207    2.391681   1.076563   27.22673   27.89217   50.21622
  rno-miR-223-3p     18.23247   0.013543   0.071138   up           0.265403   0.253033   0.314063   3.908629   7.328696   3.941176
  rno-miR-3557-3p    16.94205   0.049043   0.137085   up           0.014218   0.003466   0.00625    0.218274   0.125217   0.062003
  rno-miR-199a-5p    16.61341   8.89E-06   0.002256   up           0.306477   0.176776   0.207813   3.588832   3.928696   3.963434
  rno-miR-451-5p     15.92029   0.00089    0.023498   up           1.391785   2.157712   1.814063   33.7868    28.18609   23.41653
  rno-miR-380-5p     15.60035   0.004015   0.039631   up           0.047393   0.069324   0.101563   0.891709   1.481739   1.031797
  rno-miR-551b-3p    0.003881   0.001551   0.027567   down         5.919431   8.823224   9.196875   0.033841   0.04       0.019078
  rno-miR-153-3p     0.004766   4.37E-08   6.88E-05   down         7.663507   7.908146   7.759375   0.025381   0.036522   0.049285
  rno-miR-539-5p     0.005103   0.000688   0.020933   down         1.507109   1.649913   1.375      0.00846    0.006957   N/A
  rno-miR-376a-3p    0.005457   0.000188   0.012127   down         3.92891    5.07279    4.80625    0.018613   0.031304   0.025437
  rno-miR-124-3p     0.007493   2.61E-05   0.003452   down         92.09321   80.76256   80.40625   0.592217   0.558261   0.747218
  rno-miR-136-3p     0.007982   0.000226   0.013604   down         2.020537   2.564991   2.603125   0.025381   0.02087    0.011129
  rno-miR-129-5p     0.008243   0.041911   0.124593   down         2.519747   6.67591    2.790625   0.047377   0.043478   0.007949
  rno-miR-9a-3p      0.009872   0.000354   0.016336   down         41.50079   56.26516   48.03438   0.448393   0.542609   0.448331
  rno-miR-410-3p     0.010002   0.002631   0.032583   down         1.919431   1.443674   1.782813   0.01692    0.017391   N/A
  rno-miR-153-5p     0.011705   0.003247   0.035819   down         0.507109   0.582322   0.6875     0.001692   0.012174   N/A
  rno-miR-409a-5p    0.012151   0.00348    0.036711   down         0.36019    0.298094   0.409375   0.001692   0.006957   N/A
  rno-miR-138-5p     0.015186   0.014003   0.072249   down         8.292259   3.935875   4.757813   0.081218   0.095652   0.081081
  rno-miR-369-3p     0.015371   0.004061   0.039771   down         1.259084   1.856153   2.292188   0.025381   0.024348   0.033386
  rno-miR-495        0.015832   9.38E-06   0.002256   down         1.265403   1.377816   1.423438   0.023689   0.029565   0.011129
  rno-miR-129-2-3p   0.020383   0.005048   0.043957   down         3.361769   1.859619   2.346875   0.052453   0.074783   0.027027
  rno-miR-376b-3p    0.023408   0.001105   0.025237   down         1.962085   1.953206   2.729688   0.079526   0.052174   0.023847
  rno-miR-127-5p     0.028105   0.00953    0.06067    down         1.232227   2.107452   1.13125    0.060914   0.050435   0.014308
  rno-miR-132-5p     0.02883    0.035542   0.115982   down         1.14218    4.088388   3.13125    0.089679   0.078261   0.073132
  rno-miR-496-3p     0.029383   0.019014   0.082393   down         0.50237    1.315425   0.948438   0.025381   0.04       0.015898
  rno-miR-3542       0.029791   0.029799   0.10517    down         0.075829   0.152513   0.117188   0.003384   0.003478   N/A
  ------------------ ---------- ---------- ---------- ------------ ---------- ---------- ---------- ---------- ---------- ----------

###### Top 40 differently expressed mRNAs in microarray analysis.

  ------------------- -------------- ---------- ---------- ------------- ------------ ---------- ---------- ---------- ---------- ---------- ----------
  Genbank Accession   Gene Symbol    P-value    FDR        Fold Change   Regulation   AD-1       AD-2       AD-3       Sham -1    Sham -2    Sham -3
  NM_013414           Bglap          0.00055    0.026406   22.96703      up           8.052033   9.051468   8.575123   4.18026    4.55122    3.382667
  NM_001270665        Tnnt3          0.028149   0.128763   12.35968      up           5.806189   5.275991   8.642943   3.211319   3.209004   2.422092
  NM_012587           Ibsp           0.001096   0.031424   5.771831      up           6.252816   5.279157   5.647549   3.384729   3.16391    3.043795
  NM_013122           Igfbp2         0.038993   0.15308    5.754793      up           11.06608   9.303097   12.16206   8.300828   8.427517   8.228595
  NM_012605           Mylpf          0.026781   0.125297   5.641142      up           7.466302   7.129157   9.462192   5.464603   5.479666   5.625421
  NM_057104           Enpp2          0.038489   0.15198    5.07149       up           12.46112   10.68197   13.24472   9.646646   9.645828   10.0681
  NM_001000438        Olr1214        0.002217   0.039344   4.895564      up           5.185619   4.642926   5.070082   2.360833   3.241277   2.422092
  NM_031511           Igf2           0.049039   0.175423   4.757985      up           13.65679   11.66636   14.31541   10.78843   10.91098   11.1881
  XR_086340           LOC301444      0.014615   0.090422   4.340022      up           10.78893   10.89127   9.746195   8.448961   8.932608   7.691718
  XM_001059752        Vom2r45        3.47E-05   0.016      4.296108      up           4.366794   4.380062   4.672477   2.360833   2.327317   2.422092
  NM_001108140        Cd3e           0.003543   0.047336   4.22607       up           4.738903   4.657002   4.962316   2.360833   2.402169   3.357269
  NM_001107541        Art1           0.043071   0.162562   3.875367      up           4.757209   4.724255   6.257683   3.799408   3.654648   2.422092
  NM_031703           Aqp3           0.008524   0.068504   3.685033      up           3.96804    4.769804   4.846925   2.360833   2.390517   3.188386
  BC078859            Mpz            0.028946   0.130331   3.67334       up           7.999598   7.897556   6.286076   5.421919   5.426666   5.703367
  NM_019212           Acta1          0.047568   0.17213    3.632821      up           6.637662   6.667013   8.622218   5.496824   5.344661   5.502137
  NM_030838           Slco1a5        0.031783   0.137186   3.400608      up           8.433027   7.296741   9.147305   6.444243   6.437362   6.69809
  NM_001107564        Ano1           0.001239   0.03245    3.397198      up           8.816945   9.067116   8.695915   6.800028   7.044566   7.442346
  XM_227107           RGD1561841     0.014316   0.089396   3.391897      up           10.07803   10.32065   9.068267   8.393194   8.027146   7.760331
  NM_001109599        Pou2af1        0.008157   0.067119   3.171449      up           3.934713   4.788568   3.704984   2.360833   2.649913   2.422092
  NM_001004129        Stfa2l1        0.011619   0.07994    3.137655      up           7.900152   8.128724   7.293016   5.570128   6.459183   6.343522
  NM_022194           Il1rn          0.036753   0.148451   14.21197      down         5.016814   4.992311   5.159386   9.625172   10.56531   6.465138
  XR_361775           LOC100910367   0.004583   0.052819   10.16713      down         3.468741   4.307965   2.321873   6.875965   6.716166   6.54397
  BC098733            LOC362795      0.032448   0.138888   9.708935      down         6.844371   6.675695   7.021456   10.91333   11.35412   8.112008
  NM_017210           Dio3           0.002669   0.042782   6.519498      down         6.231844   6.621063   5.503228   9.068267   9.062721   8.339429
  XM_006255043        LOC689453      0.049874   0.177224   5.455306      down         5.015599   5.841514   3.128502   7.675495   7.21799    6.435111
  XM_006227100        LOC501467      0.030232   0.133751   5.431563      down         5.4069     6.083151   3.794581   8.035631   7.5748     6.998302
  NM_199253           Pcsk9          0.002133   0.039056   5.204765      down         2.426524   2.665853   2.946293   5.604621   5.012788   4.56076
  NM_130748           Slc38a4        0.000938   0.030292   4.934402      down         4.587482   4.637961   4.475671   7.354593   6.783875   6.471272
  NM_031512           Il1b           0.034329   0.143302   4.617557      down         4.037401   4.364745   3.874776   7.502599   6.263231   5.132481
  NM_001014221        LOC363337      0.039423   0.154047   4.587823      down         8.473712   9.35102    7.109605   10.83744   10.83451   9.855817
  XR_349427           LOC102557206   0.043126   0.162711   4.261659      down         7.166277   7.946725   5.904576   9.512047   9.477423   8.302353
  XM_006224554        Tmco5a         0.014583   0.090373   4.222635      down         5.590317   4.665117   6.381915   7.747607   7.674106   7.450068
  XM_006255374        LOC685183      0.011431   0.079358   3.885825      down         4.719262   5.091599   3.778711   6.874688   6.423315   6.166232
  NM_001014221        LOC363337      0.042926   0.162322   3.775706      down         9.380106   10.53603   8.459474   11.81476   11.39776   10.91333
  NM_001127377        LOC680663      0.001338   0.033124   3.748348      down         3.41188    3.828432   3.532797   5.766442   5.629198   5.096233
  NM_031561           Cd36           0.021348   0.110965   3.577859      down         4.227085   4.462658   4.176351   5.902704   7.071649   5.40903
  XM_006222689        LOC691712      0.017104   0.098359   3.482986      down         4.723632   5.200954   3.846046   6.733775   6.481439   5.956392
  NM_053587           S100a9         0.02089    0.109858   3.409311      down         5.465103   4.943009   3.967565   6.199166   6.637269   6.847683
  NM_001014091        Ccdc33         0.000936   0.030292   3.293413      down         2.477567   2.602366   2.926151   4.675579   4.253647   4.235609
  NM_053822           S100a8         0.006707   0.062417   3.266306      down         5.768222   5.836943   4.862041   7.00802    7.213229   7.368936
  ------------------- -------------- ---------- ---------- ------------- ------------ ---------- ---------- ---------- ---------- ---------- ----------

![**Heat map of the top 40 differentially-expressed circRNAs** (**A**), miRNAs (**B**), and mRNAs (**C**) in AD hippocampal tissue. The data are depicted as matrices in which each row represents one circRNA, miRNA, or mRNA and each column represents one of the hippocampal samples. Relative circRNA, miRNA, or mRNA expression is depicted according to the color scale shown at the top. Red and green represent high and low relative expression, respectively; -2.0, 0, and 2.0 are fold-changes in the corresponding spectrum. The magnitude of deviation from the median is represented by color saturation.](aging-10-101427-g001){#f1}

![**Volcano plot of differentially-expressed circRNAs** (**A**), miRNAs (**B**), and mRNAs (**C**) between AD and sham hippocampal samples. Volcano plots were constructed using fold-change values and *p*-values. The vertical lines correspond to 2.0-fold up- and down-regulation between normal and AD samples (N *vs.* **D**), and the horizontal lines represent *p*-values. Red plot points represent differentially-expressed circRNAs with statistical significance.](aging-10-101427-g002){#f2}

Expression profile validation
-----------------------------

To validate the accuracy and reliability of the microarray profiling data, some transcripts, including four circRNAs (rno_circRNA_001555, rno_circRNA_010684, rno_circRNA_01398, and rno_circRNA_017759), four miRNAs (rno-miR-181a-2-3p, rno-miR-124-3p, rno-miR-136-3p, and rno-miR-206-3p), and four mRNAs (IGF2, IGFBP2, S100a8, and IGF1) were randomly selected for quantitative real-time polymerase chain reaction (qRT-PCR) analysis in nine samples including those used for microarray analysis. As shown in [Fig. 3](#f3){ref-type="fig"}, the microarray data were consistent with the qRT-PCR results in terms of the expression levels of the validated ncRNAs and mRNAs.

![**qRT-PCR-validated ncRNA and mRNA expression changes.** Microarray validation by qRT-PCR. Expression levels of four circRNAs, four miRNAs, and four mRNAs were determined by qRT-PCR. Each assay was performed at least three times. \**p* \< 0.05.](aging-10-101427-g003){#f3}

GO and KEGG pathway analyses of differentially-expressed mRNAs
--------------------------------------------------------------

GO and KEGG pathway analyses allow for the functional annotation of differentially-expressed mRNAs. GO analysis indicated that the most enriched mRNAs correlated with the extracellular region part (GO: 0044421) of the cellular component analysis ([Figure 4a](#f4){ref-type="fig"}). Meanwhile, the majority of genes were related to toll-like receptor binding (GO:0035325) in the molecular functions and regulation of biological quality (GO:0065008) aspect of the biological processes analyses ([Figure 4b and 4c](#f4){ref-type="fig"}). KEGG pathway analysis indicated that 10 KEGG pathways (*p* \< 0.05) were associated with dysregulated mRNAs involved in neuroactive ligand-receptor interaction, AMP-activated protein kinase (AMPK) signaling pathway, longevity regulating pathway-multiple species, fatty acid elongation, inflammatory mediator regulation of transient receptor potential (TRP) channels, p53 signaling pathway, hematopoietic cell lineage, adipocytokine signaling pathway, focal adhesion and osteoclast differentiation ([Figure 4d](#f4){ref-type="fig"}).

![**Gene ontology (GO) enrichment and pathway analysis of differentially- expressed mRNAs** showing the most significantly enriched (-log10, *p*-value) GO terms of differentially-expressed mRNAs according to (**A**) cellular components, (**B**) molecular functions, and (**C**) biological processes. (**D**) The top ten enrichment scores (-log10, *p*-value) of significantly enriched KEGG pathways.](aging-10-101427-g004){#f4}

Prediction of circRNA-miRNA interactions
----------------------------------------

To determine the function of circRNA, interactions between circRNAs and their target miRNAs were theoretically predicted by conserved seed-matching sequences. To find the potential miRNA target, two confirmed circRNAs (rno_circRNA_008964 and rno_circRNA_017759) were selected, and circRNA-miRNA interaction was predicted using Arraystar\'s miRNA target prediction software based on the TargetScan and miRanda databases. The potential miRNA targets of rno_circRNA_008964 included rno-miR-216b-5p, rno-miR-181d-5p, rno-miR-337-5p, rno-miR-497-3p, and rno-miR-181b-5p ([Fig. 5a](#f5){ref-type="fig"}). For rno_circRNA_007879, the potential miRNA targets included rno-miR-702-5p, rno-miR-3547, rno-miR-329-5p, rno-miR-203b-5p and rno-miR-3576 ([Fig. 5](#f5){ref-type="fig"}).

![**Example of detailed annotation for circRNA-miRNA interactions.** (**A**) rno_circRNA_008964. (**B**) rno_circRNA_017759. 8mer: bases from number 2 to 8 matched perfectly, and number 1 base is A; 7mer-m8: bases from number 2 to 8 matched perfectly, and number 1 base is not A; 6mer: bases from number 2 to 7 matched perfectly, and number 1 base is not A; offset 6mer: bases from number 3 to 8 matched perfectly; imperfect match: there is imperfect base match from number 2 to 7; M: circRNA-miRNA interaction can be predicted by miRanda; T: circRNA-miRNA interaction can be predicted by TargetScan.](aging-10-101427-g005){#f5}

Construction of a circRNA-miRNA regulatory network
--------------------------------------------------

A circRNA-miRNA regulatory network, based on the microarray results, was constructed containing 245 circRNAs, 144 miRNAs and 279 relationships ([Fig. 6](#f6){ref-type="fig"}). We observed that one circRNA could regulate multiple miRNAs in different ways, while one miRNA could be regulated by multiple circRNAs. For example, circRNA_34441 was co-related to four dysregulated miRNAs and MiR-153-5p was co-related with 25 dysregulated circRNAs. Thus, there appears to be a complex circRNA-miRNA regulatory network involved in the pathogenesis of AD.

![**CircRNA-miRNA network analysis.** A total of 245 circRNAs and 144 miRNAs containing 279 relationships were selected to generate a network map. The circRNA-miRNA co-expression network was constructed with Cytoscape V3.5.0 software. Within this network, V-shaped nodes represent circRNA and octagon nodes represent miRNA. Red and green represent up- and down-regulation, respectively. Node size represents *p*-values (larger nodes for more significant *p*-values).](aging-10-101427-g006){#f6}

Construction of a circRNA-miRNA-mRNA regulatory network
-------------------------------------------------------

To explore the molecular mechanism of ncRNAs, a circRNA-miRNA-mRNA regulatory network was constructed with 140 circRNAs as decoys, 140 miRNAs as centres, and 20 mRNAs as targets based on the microarray data ([Fig. 7](#f7){ref-type="fig"}). Because there are binding sites between circRNAs and miRNAs, circRNAs could indirectly regulate miRNA target genes by competitively binding to miRNA as a miRNA sponge. For instance, we focused on miR-7a-5p, circRNA_101834 and circRNA_004690 that could regulate AQP3 expression by competing miRNA response elements (MREs) of miR-7a-5p. These data suggested that circRNAs harbor MREs and play pivotal regulatory roles in AD.

![**CircRNA-miRNA-mRNA regulatory network.** The regulatory network consists of 140 circRNAs, 140 miRNAs, and 20 genes with 503 relationships. V-shaped, octagon, and diamond nodes represent circRNA, miRNA, and mRNA, respectively. Red and green represent up- and down-regulation, respectively. Node size represents *p*-values (larger nodes for more significant *p*-values).](aging-10-101427-g007){#f7}

DISCUSSION
==========

To the best of our knowledge, this is the first integrated microarray analysis of circRNA, miRNA and mRNA expression profiles in the hippocampus of Aβ~1-42~-induced AD model rats. With FC ≥ 2.0 and *p*-value \< 0.05 thresholds, 444 up-regulated and 111 down-regulated circRNAs, 93 up-regulated and 90 down-regulated miRNAs, and 173 up-regulated and 146 down-regulated mRNAs showed significant differential expression between the AD and control groups. These transcripts are thought to be associated with the pathogenesis of AD. For instance, the S100A8 precedes Aβ plaque formation \[[@r17]\], IGFBP-2 drives AD neurodegeneration \[[@r18]\], miR-146a-5p facilitates neuroinflammation in AD pathogenesis \[[@r19]\], and miR-132-3p contributes to tau hyper-phosphorylation \[[@r20]\]. Our qRT-PCR validation showd that the qRT-PCR results and microarray data were consistent, indicating that the latter were reliable.

To better understand the biological functions and potential mechanisms of mRNAs in the pathogenesis of AD, we performed GO and KEGG pathway analysis. Among the GO terms found in this study, the extracellular region part (GO:0044421), toll-like receptor binding (GO:0035325), and the regulation of biological quality (GO:0065008) have been reported to play important roles in AD development. Remarkable among the KEGG pathways were the AMPK and p53 signaling pathways, both known to potentially mediate AD pathogenesis \[[@r21]--[@r23]\].

Increasing lines of evidence indicate that circRNAs can function as endogenous sponges to influence miRNA activity, thereby regulating other transcripts containing miRNA-binding sites \[[@r24],[@r25]\]. Therefore, we examined circRNA-miRNA interactions and found that the majority of circRNAs contained one or more miRNA binding sites based on sequence analyses. The association of miRNAs with AD indicated that circRNAs might have a regulatory role in AD. For example, rno_circRNA_003295 is potentially able to interact with rno-miR-206-3p, rno_circRNA_002441 with miR-144-3p, and rno_circRNA_012846 with rno-miR-10a-5p. Moreover, we constructed a circRNA-miRNA regulatory network to investigate potential relationships among the circRNAs and miRNAs. Our results indicated that circRNA-miRNA regulatory networks might play important roles in the pathogenesis of AD. However, beyond acting as a miRNA sponge, circRNAs might also influence mRNA transcriptional levels by interacting with the Pol II complex in the nucleus \[[@r26]\], or by directly binding to RNA-binding proteins and RNA-associated proteins to form RNA-protein complexes \[[@r27]\]. Furthermore, circRNAs can act on gene expression trans-functionally by competing with pre-mRNA splicing machinery \[[@r28]\], and endogenous circRNAs can be used as templates to encode proteins \[[@r29]\]. Therefore, the biological function of circRNA in the pathogenesis of AD requires further investigation.

Perturbations in competing endogenous RNA (ceRNA) regulatory networks (ceRNETs) including mRNAs, miRNAs, and circRNAs have been proposed to play critical roles in the pathogenesis of human disease \[[@r30]--[@r32]\]. For example, the circRNA-7/miRNA-7/UBE2A signaling pathway is significantly dysregulated in AD \[[@r33],[@r34]\]. The application of ceRNET analysis may provide a novel view of interplay between ncRNAs and mRNAs, thereby offering some insight into molecular pathways. Our results provide the first assessment of ceRNETs in AD and suggest that specific ceRNETs are involved in disease etiology and pathogenesis.

There are certain limitations to our study which should be considered when interpreting our findings. Firstly, the sample size was limited, which could have resulted in under- or over-estimation of the numbers of altered circRNAs, miRNAs, and mRNAs. Larger sample sizes are needed to confirm our findings. Secondly, our results refer only to hippocampal samples from Aβ~1-42~-induced AD rats. Further research with other AD models, using additional sample sources such as blood and cerebrospinal fluid, is now needed to more accurately capture the pathophysiology of AD. Thirdly, our analyses were performed using gene expression microarrays with limited dynamic range that lack the ability to identify novel features. RNA-sequence technology should be utilized to unravel previously inaccessible transcriptome complexities. Finally, because the functions of circRNAs and miRNAs remain largely unknown, the interpretation of our data was not straightforward. Thus, we only predicted the functions of differentially-expressed mRNAs. Future studies that overcome such limitations are now highly warranted.

In conclusion, we identified dysregulated expression profiles of circRNAs, miRNA, and mRNAs in the hippocampus of AD rats, and present an innovative data integration analysis of circRNAs, miRNAs and mRNAs. Our results indicate that ncRNAs may interact to regulate the expression of their target protein-genes involved in the pathogenesis of AD. The next step is to validate and expand these findings in future studies, which might ultimately enable us to fully elucidate the mechanisms underlying AD.

MATERIALS AND METHODS
=====================

Ethics statement
----------------

All animal protocols were approved by the Central South University (Changsha, China) Institutional Review Board and were performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. This investigation was conducted in accordance with appropriate ethical standards and the Declaration of Helsinki, as well as national and international guidelines.

Brain samples
-------------

All hippocampal tissue samples were from brain tissues obtained in our previous study \[[@r6]\]. Briefly, 20 adult male Sprague Dawley rats (250 ± 30 g) were randomly divided into AD (n = 10) and sham (n = 10) groups. We performed intracerebroventricular injections of Aβ~1-42~ oligomers into the cerebral ventricles to induce a validated AD model, as previously described \[[@r35],[@r36]\]. Briefly, the animals were anaesthetized and placed in a stereotactic frame, then the Aβ1--42 oligomers were injected bilaterally into the lateral ventricles through a stainless-steel cannula.

RNA extraction
--------------

Total RNA was extracted from each hippocampal tissue sample by soaking in TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's instructions, which mainly includes homogenization, phase separation, RNA precipitation, RNA wash and RNA solubilization. RNA quantity and quality were measured using a NanoDrop ND-1000 (Thermo Scientific, Waltham, MA, USA), and RNA integrity was assessed by standard denaturing agarose gel electrophoresis.

Microarray analysis
-------------------

Sample labelling and microarray hybridization for gene expression were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology, Santa Clara, CA, USA), which included RNA purification, transcription into fluorescent-labeled cRNA, and hybridization onto the Rat 4x44K Gene Expression Array (Agilent). Finally, the hybridized arrays were washed, fixed, and scanned using the Agilent DNA Microarray Scanner G2505C. RNA labeling and array hybridization for miRNA analysis were conducted following the Exiqon manual (Vedbaek, Denmark). After quality control, the miRCURY™ Hy3™/Hy5™ Power labeling kit (Exiqon) was used for miRNA labeling according to the manufacturer guidelines. After stopping the labeling procedure, Hy3™-labeled samples were hybridized on the Rat miRCURY LNA™ microRNA Array 7th Gen (Exiqon), according to the array manual. The slides were scanned using the Axon GenePix 4000B microarray scanner (Axon Instruments, Foster City, CA, USA). circRNA sample preparation and microarray hybridization were performed based on Arraystar standard protocols (Super RNA Labeling Kit; Arraystar, Rockville, MD, USA). Briefly, total RNAs were digested with Rnase R (Epicentre, Inc., Madison, WI, USA) to remove linear RNAs and enrich for circular RNAs. Then, the enriched circular RNAs were amplified and transcribed into fluorescent-labeled cRNA using a random priming method (Super RNA Labeling Kit). The labeled cRNAs were hybridized onto the Arraystar Rat circRNA Array (8x15K, Arraystar). After washing the slides, the arrays were scanned using the Agilent Scanner G2505C. All data collection was performed using Agilent Feature Extraction software (version 11.0.1.1). KangChen Bio-tech (Shanghai, China) performed all microarray analyses.

Quantitative real-time polymerase chain reaction (qRT-PCR) validation
---------------------------------------------------------------------

As previously described \[[@r31]\], total RNA was isolated using TRIzol Reagent, and then reverse-transcribed into cDNA using SuperScript III Reverse Transcriptase (Invitrogen) according to the manufacturer's instruction. An Applied Biosystems ViiA™7 Real-Time PCR System and 2× PCR Master Mix were used to perform qRT-PCR (Arraystar) in accordance with the manufacturer\'s instructions. The relative circRNA and mRNA expression levels were calculated using the 2^-ΔΔCt^ method and were normalized to GAPDH as an endogenous reference transcript \[[@r37]\]. miRNA expression levels were normalized to that of U6. The specific primers for each gene are listed in [Table 4](#t4){ref-type="table"}. Data shown represent the means of three experiments.

###### Primers designed for qRT-PCR validation of candidate circRNAs, miRNAs, and mRNAs.

  -------------------- ------------------------------- -------------------------------- ------------------- --------
                       Forward primer                  Reverse Primer                   PrProduct length\   Tm(°C)
                                                                                        (bp)                

  rno_circRNA_001555   5'- ATGAGCAATGACTCCCCAGAA-3'    5'- GAGAGTATGGTCTGTTGCGTTG-3'    60                  60

  rno_circRNA_010684   5'- TGGATCTAAAGCAGCTACAGAA-3'   5'- CTTTGGTTCCATTCATCCTTAT-3'    82                  60

  rno_circRNA_013981   5'- CTACCTTGAGCTGCACATACTG-3'   5'- TTTGTCCACCACCTTTGCT-3'       58                  60

  rno_circRNA_017759   5'- GAGTATCCACTGGTGACGACTG-3'   5'- AATATGCTGATCTTGTTTTCACC-3'   69                  60

  rno-miR-181a-2-3p    5'-GGACCACTGACCGTTGAC-3'        5'-CAGTGCGTGTCGTGGAG-3'          64                  60

  rno-miR-206-3p       5'- TGGGGTGGAATGTAAGGAAGT-3'    5'-CAGTGCGTGTCGTGGAGT-3'         65                  60

  rno-miR-124-3p       5'-GGGTAAGGCACGCGGT-3'          5'-GTGCGTGTCGTGGAGTCG-3'         61                  60

  rno-miR-136-3p       5'- GGGGACATCATCGTCTCAAAT -3'   5'-CAGTGCGTGTCGTGGAGT-3'         65                  60

  IGFBP2               5'- TCTACTCCCTGCATATCCCCA-3'    5'- GGTTCACACACCAGCACTCC-3'      105                 60

  IGF2                 5'- GCTTGTTGACACGCTTCAGTT-3'    5'- TAGACACGTCCCTCTCGGA-3'       179                 60

  IGF1                 5'- GGGCATTGTGGATGAGTGTTG -3'   5'- GCTGGGACTTCTGAGTCTTGG -3'    148                 60

  S100A8               5'-GGGAATCACCATGCCCTCTAC-3'     5'-GCCCACCCTTATCACCAACAC-3'      168                 60
  -------------------- ------------------------------- -------------------------------- ------------------- --------

GO annotations and KEGG pathway analyses
----------------------------------------

GO annotations and KEGG pathway analyses were performed to investigate the roles of all differentially-expressed mRNAs, as previously described \[[@r38],[@r39]\]. Briefly, GO analysis was applied to elucidate genetic regulatory networks of interest by forming hierarchical categories according to the molecular functions, biological processes, and cellular component aspects of the differentially expressed genes (<http://www.geneontology.org>). The -log10 (*p*-value) denotes enrichment scores that represent the significance of GO term enrichment among differentially-expressed genes. KEGG pathway analyses were performed to explore significant pathways associated with the differentially-expressed genes (<http://www.genome.jp/kegg/>). The -log10 (*p*-value) denotes an enrichment score for the significance of pathway correlations.

Annotation for circRNA-miRNA interaction
----------------------------------------

As described previously \[[@r40],[@r41]\], circRNA-miRNA interactions were predicted with Arraystar\'s home-made miRNA target prediction software based on TargetScan (<http://www.targetscan.org/>) and miRanda ([www.microrna.org/](http://www.microrna.org/)). The top five putative target miRNAs were identified. Then, we constructed a circRNA-miRNA regulatory network using the Cytoscape software V3.5.0 (San Diego, CA, USA).

CircRNA-associated ceRNA network construction
---------------------------------------------

The circRNA-associated ceRNA network was constructed and visually displayed using the Cytoscape software V3.5.0 (San Diego, CA, USA) based on microarray data analysis results, as previous described \[[@r42]\]. Different shapes and colors represent different RNA types and regulated relationships, respectively. Node size was inversely proportion to the *p*-value.

Statistical analysis
--------------------

All data were analysed using SPSS version 22.0 software (IBM Corp. Armonk, NY, USA) and presented as mean ± standard error of the mean (SEM). Student's t-tests were used for comparisons between two groups, whereas one-way analysis of variance was performed for repeated measures. False discovery rates were calculated to correct *p-*values. Differences with *p* \< 0.05 were considered to be statistically significant. Fold changes (FCs) and Student's t-tests were used to determine the statistical significance of the microarray results. FC ≥ 2 and *p* \< 0.05 were used as thresholds for designating differentially-expressed ncRNAs and mRNAs.
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